<!DOCTYPE html>
<!--
==============================================================================
           "GitHub HTML5 Pandoc Template" v2.1 — by Tristano Ajmone           
==============================================================================
Copyright © Tristano Ajmone, 2017, MIT License (MIT). Project's home:

- https://github.com/tajmone/pandoc-goodies

The CSS in this template reuses source code taken from the following projects:

- GitHub Markdown CSS: Copyright © Sindre Sorhus, MIT License (MIT):
  https://github.com/sindresorhus/github-markdown-css

- Primer CSS: Copyright © 2016-2017 GitHub Inc., MIT License (MIT):
  http://primercss.io/

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The MIT License 

Copyright (c) Tristano Ajmone, 2017 (github.com/tajmone/pandoc-goodies)
Copyright (c) Sindre Sorhus <sindresorhus@gmail.com> (sindresorhus.com)
Copyright (c) 2017 GitHub Inc.

"GitHub Pandoc HTML5 Template" is Copyright (c) Tristano Ajmone, 2017, released
under the MIT License (MIT); it contains readaptations of substantial portions
of the following third party softwares:

(1) "GitHub Markdown CSS", Copyright (c) Sindre Sorhus, MIT License (MIT).
(2) "Primer CSS", Copyright (c) 2016 GitHub Inc., MIT License (MIT).

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
==============================================================================-->
<html>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Sepsis in adults  v2.0 MeG-CLS-043</title>
  <style type="text/css">
@charset "UTF-8";.markdown-body{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;color:#24292e;font-family:-apple-system,system-ui,BlinkMacSystemFont,"Segoe UI",Helvetica,Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol";font-size:16px;line-height:1.5;word-wrap:break-word;box-sizing:border-box;min-width:200px;max-width:980px;margin:0 auto;padding:45px}.markdown-body a{color:#0366d6;background-color:transparent;text-decoration:none;-webkit-text-decoration-skip:objects}.markdown-body a:active,.markdown-body a:hover{outline-width:0}.markdown-body a:hover{text-decoration:underline}.markdown-body a:not([href]){color:inherit;text-decoration:none}.markdown-body strong{font-weight:600}.markdown-body h1,.markdown-body h2,.markdown-body h3,.markdown-body h4,.markdown-body h5,.markdown-body h6{margin-top:24px;margin-bottom:16px;font-weight:600;line-height:1.25}.markdown-body h1{font-size:2em;margin:.67em 0;padding-bottom:.3em;border-bottom:1px solid #eaecef}.markdown-body h2{padding-bottom:.3em;font-size:1.5em;border-bottom:1px solid #eaecef}.markdown-body h3{font-size:1.25em}.markdown-body h4{font-size:1em}.markdown-body h5{font-size:.875em}.markdown-body h6{font-size:.85em;color:#6a737d}.markdown-body img{border-style:none}.markdown-body svg:not(:root){overflow:hidden}.markdown-body hr{box-sizing:content-box;height:.25em;margin:24px 0;padding:0;overflow:hidden;background-color:#e1e4e8;border:0}.markdown-body hr::before{display:table;content:""}.markdown-body hr::after{display:table;clear:both;content:""}.markdown-body input{margin:0;overflow:visible;font:inherit;font-family:inherit;font-size:inherit;line-height:inherit}.markdown-body [type=checkbox]{box-sizing:border-box;padding:0}.markdown-body *{box-sizing:border-box}.markdown-body blockquote{margin:0}.markdown-body ol,.markdown-body ul{padding-left:2em}.markdown-body ol ol,.markdown-body ul ol{list-style-type:lower-roman}.markdown-body ol ol,.markdown-body ol ul,.markdown-body ul ol,.markdown-body ul ul{margin-top:0;margin-bottom:0}.markdown-body ol ol ol,.markdown-body ol ul ol,.markdown-body ul ol ol,.markdown-body ul ul ol{list-style-type:lower-alpha}.markdown-body li>p{margin-top:16px}.markdown-body li+li{margin-top:.25em}.markdown-body dd{margin-left:0}.markdown-body dl{padding:0}.markdown-body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:600}.markdown-body dl dd{padding:0 16px;margin-bottom:16px}.markdown-body code{font-family:SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace}.markdown-body pre{font:12px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;word-wrap:normal}.markdown-body blockquote,.markdown-body dl,.markdown-body ol,.markdown-body p,.markdown-body pre,.markdown-body table,.markdown-body ul{margin-top:0;margin-bottom:16px}.markdown-body blockquote{padding:0 1em;color:#6a737d;border-left:.25em solid #dfe2e5}.markdown-body blockquote>:first-child{margin-top:0}.markdown-body blockquote>:last-child{margin-bottom:0}.markdown-body table{display:block;width:100%;overflow:auto;border-spacing:0;border-collapse:collapse}.markdown-body table th{font-weight:600}.markdown-body table td,.markdown-body table th{padding:6px 13px;border:1px solid #dfe2e5}.markdown-body table tr{background-color:#fff;border-top:1px solid #c6cbd1}.markdown-body table tr:nth-child(2n){background-color:#f6f8fa}.markdown-body img{max-width:100%;box-sizing:content-box;background-color:#fff}.markdown-body code{padding:.2em 0;margin:0;font-size:85%;background-color:rgba(27,31,35,.05);border-radius:3px}.markdown-body code::after,.markdown-body code::before{letter-spacing:-.2em;content:" "}.markdown-body pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}.markdown-body .highlight{margin-bottom:16px}.markdown-body .highlight pre{margin-bottom:0;word-break:normal}.markdown-body .highlight pre,.markdown-body pre{padding:16px;overflow:auto;font-size:85%;line-height:1.45;background-color:#f6f8fa;border-radius:3px}.markdown-body pre code{display:inline;max-width:auto;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}.markdown-body pre code::after,.markdown-body pre code::before{content:normal}.markdown-body .full-commit .btn-outline:not(:disabled):hover{color:#005cc5;border-color:#005cc5}.markdown-body kbd{box-shadow:inset 0 -1px 0 #959da5;display:inline-block;padding:3px 5px;font:11px/10px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;color:#444d56;vertical-align:middle;background-color:#fcfcfc;border:1px solid #c6cbd1;border-bottom-color:#959da5;border-radius:3px;box-shadow:inset 0 -1px 0 #959da5}.markdown-body :checked+.radio-label{position:relative;z-index:1;border-color:#0366d6}.markdown-body .task-list-item{list-style-type:none}.markdown-body .task-list-item+.task-list-item{margin-top:3px}.markdown-body .task-list-item input{margin:0 .2em .25em -1.6em;vertical-align:middle}.markdown-body::before{display:table;content:""}.markdown-body::after{display:table;clear:both;content:""}.markdown-body>:first-child{margin-top:0!important}.markdown-body>:last-child{margin-bottom:0!important}.Alert,.Error,.Note,.Success,.Warning{padding:11px;margin-bottom:24px;border-style:solid;border-width:1px;border-radius:4px}.Alert p,.Error p,.Note p,.Success p,.Warning p{margin-top:0}.Alert p:last-child,.Error p:last-child,.Note p:last-child,.Success p:last-child,.Warning p:last-child{margin-bottom:0}.Alert{color:#246;background-color:#e2eef9;border-color:#bac6d3}.Warning{color:#4c4a42;background-color:#fff9ea;border-color:#dfd8c2}.Error{color:#911;background-color:#fcdede;border-color:#d2b2b2}.Success{color:#22662c;background-color:#e2f9e5;border-color:#bad3be}.Note{color:#2f363d;background-color:#f6f8fa;border-color:#d5d8da}.Alert h1,.Alert h2,.Alert h3,.Alert h4,.Alert h5,.Alert h6{color:#246;margin-bottom:0}.Warning h1,.Warning h2,.Warning h3,.Warning h4,.Warning h5,.Warning h6{color:#4c4a42;margin-bottom:0}.Error h1,.Error h2,.Error h3,.Error h4,.Error h5,.Error h6{color:#911;margin-bottom:0}.Success h1,.Success h2,.Success h3,.Success h4,.Success h5,.Success h6{color:#22662c;margin-bottom:0}.Note h1,.Note h2,.Note h3,.Note h4,.Note h5,.Note h6{color:#2f363d;margin-bottom:0}.Alert h1:first-child,.Alert h2:first-child,.Alert h3:first-child,.Alert h4:first-child,.Alert h5:first-child,.Alert h6:first-child,.Error h1:first-child,.Error h2:first-child,.Error h3:first-child,.Error h4:first-child,.Error h5:first-child,.Error h6:first-child,.Note h1:first-child,.Note h2:first-child,.Note h3:first-child,.Note h4:first-child,.Note h5:first-child,.Note h6:first-child,.Success h1:first-child,.Success h2:first-child,.Success h3:first-child,.Success h4:first-child,.Success h5:first-child,.Success h6:first-child,.Warning h1:first-child,.Warning h2:first-child,.Warning h3:first-child,.Warning h4:first-child,.Warning h5:first-child,.Warning h6:first-child{margin-top:0}h1.title,p.subtitle{text-align:center}h1.title.followed-by-subtitle{margin-bottom:0}p.subtitle{font-size:1.5em;font-weight:600;line-height:1.25;margin-top:0;margin-bottom:16px;padding-bottom:.3em}div.line-block{white-space:pre-line}
  </style>
  <style type="text/css">code{white-space: pre;}</style>
  <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv-printshiv.min.js"></script>
  <![endif]-->
</head>
<body>
<article class="markdown-body">
<h1 id="sepsis-in-adults">Sepsis in adults</h1>
<h2 id="executive-summary"><em>Executive summary</em></h2>
<h2 id="introduction">Introduction</h2>
<p>Sepsis is a life-threatening syndrome which must be rapidly recognized and treated. It is a response of the body’s immune system that results in organ dysfunction or failure. Evidence shows that the patient’s chances of survival are directly related to the speed at which treatment is started.</p>
<h2 id="target-users">Target users</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Nurses</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Doctors</p>
</div></li>
</ul>
<h2 id="target-area-of-use">Target area of use </h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Outpatient department</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ward</p>
</div></li>
</ul>
<h2 id="key-areas-of-focus-new-additions-changes">Key areas of focus / New additions / Changes </h2>
<p>This guideline outlines the rapid recognition and response required to treat sepsis. It summarises the empirical antibiotics appropriate in our setting.</p>
<h2 id="limitations">Limitations</h2>
<p>We do not have access to HDU level care.</p>
<h2 id="presenting-symptoms-and-signs">Presenting symptoms and signs</h2>
<p>Sepsis can present in many different ways depending on where the infection is. Immunocompromised patients may not mount the same response as other patients.</p>
<p>Common symptoms are:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Fever, with or without shaking chills (Temperature &gt; 38ºC or &lt; 36 ºC)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Cough</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Pain (abdominal, joint, headache)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Hypotension</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Impaired mental status</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Increased respiratory rate (&gt;20breaths/min)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Signs of end organ perfusion (Warm flushed skin, oligura, ileus or absent bowel signs)</p>
</div></li>
</ul>
<h2 id="examination-findings">Examination findings</h2>
<h2 id="depend-on-the-type-of-sepsis.">Depend on the type of sepsis.</h2>
<p>Patients should undergo a full examination including:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Cardiovascular</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Respiratory</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Abdominal</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ear, nose and throat</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>General; look for any joint swellings, skin rashes , abscess</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Neurological; any signs of meningism</p>
</div></li>
</ul>
<p>It is very important to look for signs of immunosuppression.</p>
<h3 id="differential-diagnosis">Differential diagnosis</h3>
<p>The list is endless! Heart failure, asthma, severe COPD, hypoglycaemia, tuberculosis can all present like sepsis.</p>
<h2 id="management">Management</h2>
<p>If you think of sepsis, admit to the ward and use the sepsis cards to prioritise care.</p>
<p>In OPD, you can calculate a qSOFA score. Score 1 for each of:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Systolic blood pressure (&lt;100mmHg)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Tachypnoea (RR &gt;22 per minute)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Altered mental state</p>
</div></li>
</ul>
<p>A score of 2 or more indicates that a doctor should consider sepsis and intervene rapidly.</p>
<h3 id="investigations">Investigations</h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>FBC, U+E, LFTs, glucose</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Take 2 x 10mls for blood culture</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Chest x-ray</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Urine dip</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>HIV test if status unknown</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Lumbar puncture if meningitis suspected and no focal neurological deficit</p>
</div></li>
<li><p>Abdomino-pelvic USS is an intra-abdominal abscess is suspected.</p></li>
</ul>
<h3 id="management-1">Management</h3>
<p><em>The Golden Hour</em>: all patients who are septic should have IV fluids, oxygen (if required) and IV antibiotics within the first hour of admission.</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>IV access</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Bloods (as above)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Assess fluid status – if hypotensive, which may be severe in sepsis, requires rapid, large volume infusions of IVF (30 <span data-custom-style="nowrap">mL/kg)</span> are indicated as initial therapy for severe sepsis or septic shock, unless there is convincing evidence of significant pulmonary oedema.</p>
</div></li>
</ul>
<div data-custom-style="List Paragraph">
<p>Fluid therapy should be administered in well-defined (eg, 500 mL), rapidly infused boluses. The clinical and hemodynamic response and the presence or absence of pulmonary oedema must be assessed before and after each bolus. Intravenous fluid challenges can be repeated until blood pressure and tissue perfusion are acceptable, pulmonary oedema ensues, or fluid fails to augment perfusion.</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p>IV antibiotics – see below</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>At least 1 hourly observations in first few hours of admission</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Urinary catheter to monitor fluid status</p>
</div></li>
</ul>
<p>The antibiotic given depends on the presumed source of sepsis.</p>
<table>
<thead>
<tr class="header">
<th></th>
<th><strong>IV therapy</strong></th>
<th><strong>Oral therapy for step down</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Source unknown</strong></td>
<td>Ampicillin 1 g 8 hourly + Gentamicin 5-7.5 mg/kg once daily</td>
<td></td>
</tr>
<tr class="even">
<td><strong>Respiratory</strong></td>
<td><p>Benzylpenicillin 1.2 g 6 hourly increased if necessary to 2.4 g in more serious infections + Chloramphenicol 500 mg 6 hourly</p>
<p>If atypical suspected, add azithromycin 500mg OD for 3 days</p></td>
<td><p>Amoxicillin 500 mg 8 hourly</p>
<p>OR</p>
<p>Doxycycline 200 mg OD</p></td>
</tr>
<tr class="odd">
<td><strong>Urinary</strong></td>
<td>Ampicillin 1 g 8 hourly + Gentamicin 5-7.5 mg/kg once daily</td>
<td>Nitrofurantoin 50 mg QDS</td>
</tr>
<tr class="even">
<td><strong>Soft tissue</strong></td>
<td><p>Cloxacillin 1 g QDS (2 g in severe infection )</p>
<p>+ Benzypenicillin or Ampicillin if severe</p></td>
<td>Cloxacillin 500 mg QDS</td>
</tr>
<tr class="odd">
<td><strong>Meningitis</strong></td>
<td>Ceftriaxone 2 g 12 hourly for 14 days depending on organism</td>
<td></td>
</tr>
<tr class="even">
<td><strong>Abdominal sepsis</strong></td>
<td>Triple therapy; Ampicillin 1 g 8 hourly + Gentamicin 5-7.5 mg/kg OD + Metronidazole 500 mg TDS</td>
<td><p>Depends on source; e.g.cholecystitis; amoxicillin and metronidazole</p>
<p>Spontaneous bacterial peritonitis; ciprofloxacin and metronidazole</p></td>
</tr>
<tr class="odd">
<td><strong>Invasive fungal infections</strong></td>
<td><p>Fluconazole (800 mg [12 <span data-custom-style="nowrap">mg/kg]</span> loading dose, then 400 mg [6 <span data-custom-style="nowrap">mg/kg]</span> IV daily)</p>
<p>(Lipid formulation amphotericin B (3 to 5 <span data-custom-style="nowrap">mg/kg</span> IV daily) is an alternative but is not usually available)</p></td>
<td>Oral therapy (at the same dose) should be given to patients who are able to take oral medications,</td>
</tr>
</tbody>
</table>
<p><strong>Notes:</strong></p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Gentamicin – one dose can be given before the renal function is known, but further doses should only be continued if renal function is normal. There are very few circumstances where a course should continue beyond 5 days.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ceftriaxone – is often used as a second line option where there seems to be a failure to respond to first line medications. If there is no clear diagnosis, it should usually be stopped after 5 or at most 7 days.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>If not responding – look for a reason and consider changing the antibiotics.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Blood cultures should be followed up after 48 hours with a phone call to the microbiology lab.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>If after 48 hours, there is no clear diagnosis and the patient is clinically improved and stable consider switching to oral antibiotics.</p>
</div></li>
</ul>
<h2 id="key-issues-for-nursing-care">Key Issues for Nursing care</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>The Golden Hour – Make sure antibiotics and fluids are given within the first hour.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Monitor patients using the Early Warning Score.</p>
</div></li>
</ul>
<h2 id="references">References</h2>
<h2 id="sepsis-recognition-diagnosis-and-early-management.-nice-guidelines-published-july-2016.-available-at-httpswww.nice.org.ukguidanceng51chapterrecommendationsstratifying-risk-of-severe-illness-or-death-from-sepsis">Sepsis; recognition , diagnosis and early Management. NICE guidelines, published July 2016. Available at <a href="https://www.nice.org.uk/guidance/NG51/chapter/Recommendations#stratifying-risk-of-severe-illness-or-death-from-sepsis"><span data-custom-style="Hyperlink">https://www.nice.org.uk/guidance/NG51/chapter/Recommendations#stratifying-risk-of-severe-illness-or-death-from-sepsis</span></a> </h2>
<p>SIRS, qSOFA and new Sepsis definition. Marik P, Taeb A. Journal of Throacic disease, 2017 Apr; 9(4): 943-945. Available at <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418298/"><span data-custom-style="Hyperlink">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418298/</span></a></p>
<p>qSOFA Score for Patients with Sepsis in Low and Middle Income countries. Adhikari N, Rubenfeld D. JAMA, published online May 2018 DOI 10.1001/jama.2018.6413. Available at <a href="https://jamanetwork.com/journals/jama/fullarticle/2681800"><span data-custom-style="Hyperlink">https://jamanetwork.com/journals/jama/fullarticle/2681800</span></a></p>
<table>
<thead>
<tr class="header">
<th><strong>Written by:</strong></th>
<th>Name: Caitlin Jones</th>
<th>Date: 31 May 2018</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Reviewed by:</strong></td>
<td>Name: Karen Forrest</td>
<td>Date: 14 June 2018</td>
</tr>
<tr class="even">
<td></td>
<td>Name: Amie Secka</td>
<td>Date: 06 July 2020</td>
</tr>
<tr class="odd">
<td><strong>Version:</strong></td>
<td><strong>Change history:</strong></td>
<td><strong>Review due date:</strong></td>
</tr>
<tr class="even">
<td>1.0</td>
<td>New document</td>
<td>31 July 2020</td>
</tr>
<tr class="odd">
<td>1.1</td>
<td>Executive summary added</td>
<td>31 July 2020</td>
</tr>
<tr class="even">
<td>2.0</td>
<td>Reviewed with changes</td>
<td>01 November 2022</td>
</tr>
<tr class="odd">
<td>Review Comments (<em>if applicable)</em></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</article>
</body>
</html>
